Pre-AuthorizationAddiction Medicine
Prior auth for buprenorphine doesn't have to be a full-time job.
The Problem
MAT medications — buprenorphine, naltrexone, injectable naltrexone — require prior authorization that arrives slowly, expires quickly, and often needs annual renewal. Managing it manually means patients occasionally run out of medication because paperwork was missed. That is a clinical failure.
The Solution
clinIQ pre-auth tracks every authorization by medication and patient. Expiration alerts fire 30 days before coverage ends. Renewal requests are queued automatically. No patient runs out of MAT medication because a PA renewal was missed in a paper stack.
See Pre-Authorization for Addiction Medicine in action.
15-minute demo. We'll configure it for your addiction medicine workflow. No pitch deck, no pressure.
Book a Demo